Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electra-1; Elective Cardioversion of Atrial Fibrillation at Home by Advanced Practice Providers; A Feasibility Study in Dutch Emergency Medical Service

NCT06322836 is registered in ClinicalTrials.gov with RAV Brabant MWN as lead sponsor.

NCT NCT06322836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06322836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electra-1; Elective Cardioversion of Atrial Fibrillation at Home by Advanced Practice Providers; A Feasibility Study in Dutch Emergency Medical Service
Lead sponsor
RAV Brabant MWN
Phase
Not applicable
Overall status
Completed
Start date
February 7, 2024
Completion date
February 10, 2025
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electric countershock, emergency medical services